ZNFX1 Anti-sense RNA 1 Promotes the Tumorigenesis of Prostate Cancer by Regulating C-Myc Expression Via a Regulatory Network of Competing Endogenous RNAs

Overview

Journal Cell Mol Life Sci

Publisher Springer

Specialty Biology

Date 2019 Jul 20

PMID 31321444

Citations 11

Authors

Xiaolu Cui

Chiyuan Piao

Chengcheng Lv

Xuyong Lin

Zhe Zhang

Xiankui Liu

Affiliations

Soon will be listed here.

Abstract

ZNFX1 anti-sense RNA 1 (ZFAS1) has been indicated in the tumorigenesis of various human cancers. However, the role of ZFAS1 in prostate cancer (PCa) progression and the underlying mechanisms remain incompletely understood. In the present study, we discovered that ZFAS1 is upregulated in PCa and that ZFAS1 overexpression predicted poor clinical outcomes. ZFAS1 overexpression notably promoted the proliferation, invasion, and epithelial-mesenchymal transition of PCa cells. Furthermore, we not only discovered that miR-27a/15a/16 are targeted by ZFAS1, which binds to their miRNA-response elements, but also revealed their tumor suppressor roles in PCa. We also identified that the Hippo pathway transducer YAP1, as well as its cooperator, TEAD1, are common downstream targets of miR-27a/15a/16. In addition, H3K9 demethylase KDM3A was found to be another target gene of miR-27a. Importantly, YAP1, TEAD1, and KDM3A all act as strong c-Myc inducers in an androgen-independent manner. Taken together, we suggest a regulatory network in which ZFAS1 is capable of enhancing c-Myc expression by inducing the expression of YAP1, TEAD1, and KDM3A through crosstalk with their upstream miRNAs, thereby globally promoting prostate cancer tumorigenesis.

Citing Articles

Research Progress of Long Non-coding RNA-ZFAS1 in Malignant Tumors.

Liu X, Ma Z, Zhang X, Li S, An J, Luo Z Cell Biochem Biophys. 2024; 82(4):3145-3156.

PMID: 39060915 DOI: 10.1007/s12013-024-01441-3.

LncRNA SNHG4 promotes prostate cancer cell survival and resistance to enzalutamide through a let-7a/RREB1 positive feedback loop and a ceRNA network.

Dong Q, Qiu H, Piao C, Li Z, Cui X J Exp Clin Cancer Res. 2023; 42(1):209.

PMID: 37596700 PMC: 10436424. DOI: 10.1186/s13046-023-02774-2.

Integrative Analysis and Experimental Validation Indicated That SNHG17 Is a Prognostic Marker in Prostate Cancer and a Modulator of the Tumor Microenvironment via a Competitive Endogenous RNA Regulatory Network.

Li J, Yu H, Yao J, Jiang Z, Li Z, Cui X Oxid Med Cell Longev. 2022; 2022:1747604.

PMID: 35864871 PMC: 9296331. DOI: 10.1155/2022/1747604.

Astragalus mongholicus Bunge-Curcuma aromatica Salisb. suppresses growth and metastasis of colorectal cancer cells by inhibiting M2 macrophage polarization via a Sp1/ZFAS1/miR-153-3p/CCR5 regulatory axis.

Gu J, Sun R, Tang D, Liu F, Chang X, Wang Q Cell Biol Toxicol. 2022; 38(4):679-697.

PMID: 35072892 DOI: 10.1007/s10565-021-09679-w.

Regulation of Neuroendocrine-like Differentiation in Prostate Cancer by Non-Coding RNAs.

Slabakova E, Kahounova Z, Prochazkova J, Soucek K Noncoding RNA. 2021; 7(4).

PMID: 34940756 PMC: 8704250. DOI: 10.3390/ncrna7040075.

References

Xue M, Chen W, Xiang A, Wang R, Chen H, Pan J . Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1. Mol Cancer. 2017; 16(1):143. PMC: 5574139. DOI: 10.1186/s12943-017-0714-8. View

Wang Z, Wu Y, Wang H, Zhang Y, Mei L, Fang X . Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility. Proc Natl Acad Sci U S A. 2013; 111(1):E89-98. PMC: 3890879. DOI: 10.1073/pnas.1319190110. View

Karreth F, Reschke M, Ruocco A, Ng C, Chapuy B, Leopold V . The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo. Cell. 2015; 161(2):319-32. PMC: 6922011. DOI: 10.1016/j.cell.2015.02.043. View

Goda S, Isagawa T, Chikaoka Y, Kawamura T, Aburatani H . Control of histone H3 lysine 9 (H3K9) methylation state via cooperative two-step demethylation by Jumonji domain containing 1A (JMJD1A) homodimer. J Biol Chem. 2013; 288(52):36948-56. PMC: 3873553. DOI: 10.1074/jbc.M113.492595. View

Moroishi T, Hansen C, Guan K . The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer. 2015; 15(2):73-79. PMC: 4562315. DOI: 10.1038/nrc3876. View

Jiao S, Wang H, Shi Z, Dong A, Zhang W, Song X . A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer. Cancer Cell. 2014; 25(2):166-80. DOI: 10.1016/j.ccr.2014.01.010. View

Xue G, Yan H, Zhang Y, Hao L, Zhu X, Mei Q . c-Myc-mediated repression of miR-15-16 in hypoxia is induced by increased HIF-2α and promotes tumor angiogenesis and metastasis by upregulating FGF2. Oncogene. 2014; 34(11):1393-406. DOI: 10.1038/onc.2014.82. View

Colangelo T, Polcaro G, Ziccardi P, Muccillo L, Galgani M, Pucci B . The miR-27a-calreticulin axis affects drug-induced immunogenic cell death in human colorectal cancer cells. Cell Death Dis. 2016; 7:e2108. PMC: 4849155. DOI: 10.1038/cddis.2016.29. View

Askarian-Amiri M, Crawford J, French J, Smart C, Smith M, Clark M . SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer. RNA. 2011; 17(5):878-91. PMC: 3078737. DOI: 10.1261/rna.2528811. View

10.

Tay Y, Kats L, Salmena L, Weiss D, Tan S, Ala U . Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell. 2011; 147(2):344-57. PMC: 3235920. DOI: 10.1016/j.cell.2011.09.029. View

11.

Vlachos I, Zagganas K, Paraskevopoulou M, Georgakilas G, Karagkouni D, Vergoulis T . DIANA-miRPath v3.0: deciphering microRNA function with experimental support. Nucleic Acids Res. 2015; 43(W1):W460-6. PMC: 4489228. DOI: 10.1093/nar/gkv403. View

12.

Wang K, Liu C, Zhou L, Wang J, Wang M, Zhao B . APF lncRNA regulates autophagy and myocardial infarction by targeting miR-188-3p. Nat Commun. 2015; 6:6779. DOI: 10.1038/ncomms7779. View

13.

Wang H, Huo X, Yang X, He J, Cheng L, Wang N . STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4. Mol Cancer. 2017; 16(1):136. PMC: 5558651. DOI: 10.1186/s12943-017-0680-1. View

14.

Pan D . The hippo signaling pathway in development and cancer. Dev Cell. 2010; 19(4):491-505. PMC: 3124840. DOI: 10.1016/j.devcel.2010.09.011. View

15.

Ulitsky I, Bartel D . lincRNAs: genomics, evolution, and mechanisms. Cell. 2013; 154(1):26-46. PMC: 3924787. DOI: 10.1016/j.cell.2013.06.020. View

16.

Sun Y, Yang X, Liu M, Tang H . B4GALT3 up-regulation by miR-27a contributes to the oncogenic activity in human cervical cancer cells. Cancer Lett. 2016; 375(2):284-292. DOI: 10.1016/j.canlet.2016.03.016. View

17.

Du Z, Sun T, Hacisuleyman E, Fei T, Wang X, Brown M . Integrative analyses reveal a long noncoding RNA-mediated sponge regulatory network in prostate cancer. Nat Commun. 2016; 7:10982. PMC: 4796315. DOI: 10.1038/ncomms10982. View

18.

Zhang A, Zhao J, Kim J, Fong K, Yang Y, Chakravarti D . LncRNA HOTAIR Enhances the Androgen-Receptor-Mediated Transcriptional Program and Drives Castration-Resistant Prostate Cancer. Cell Rep. 2015; 13(1):209-221. PMC: 4757469. DOI: 10.1016/j.celrep.2015.08.069. View

19.

Kim J, Roh M, Doubinskaia I, Algarroba G, Eltoum I, Abdulkadir S . A mouse model of heterogeneous, c-MYC-initiated prostate cancer with loss of Pten and p53. Oncogene. 2011; 31(3):322-32. PMC: 3179816. DOI: 10.1038/onc.2011.236. View

20.

Chandrashekar D, Bashel B, Balasubramanya S, Creighton C, Ponce-Rodriguez I, Chakravarthi B . UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia. 2017; 19(8):649-658. PMC: 5516091. DOI: 10.1016/j.neo.2017.05.002. View